HIF1A and prostate cancer: Moreover, this compound revealed the positive effect on prostate cancer by the inhibition of HIF-1α-mediated androgen receptor signaling and reducing proliferation of prostate cancer in vitro and in vivo (Figure 2 and Figure 3) [102,103,104].